Rutledge Ellis-Behnke

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Arch Biosurgery, Inc., Massachusetts Institute of Technology, Versitech, Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rutledge Ellis-Behnke. Retrieved from https://idiyas.com/inventor/rutledge-ellis-behnke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 94.4

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 188(Granted Patents)

Location History:

Hong Kong, CN (2016)
Myrtle Beach, SC (US) (2015 - 2020)
Canton, MA (US) (2010 - 2023)

Company Filing History:

9 out of 9

Arch Biosurgery, Inc.

patents

7 out of 8,578

Massachusetts Institute of Technology

The University of Hong Kong

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12390552 - Self-assembling peptide gel formulation and methods of use (2025-08-19),

2. 11839694 - Compositions and methods for promoting hemostasis and other physiological activities (2023-12-12),

3. 10869907 - Implantable meshes for controlling the movement of fluids (2020-12-22),

4. 10682386 - Compositions for prevention of adhesions and other barrier applications (2020-06-16),

5. 10314886 - Implantable meshes for controlling the movement of fluids (2019-06-11),

6. 10137166 - Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions (2018-11-27),

7. 9821022 - Implantable meshes for controlling the movement of fluids (2017-11-21),

8. 9789157 - Compositions for prevention of adhesions and other barrier applications (2017-10-17),

9. 9511113 - Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions (2016-12-06),

10. 9439941 - Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells (2016-09-13),

11. 9415084 - Treatment of leaky or damaged tight junctions and enhancing extracellular matrix (2016-08-16),

12. 9364513 - Compositions and methods for promoting hemostasis and other physiological activities (2016-06-14),

13. 9339476 - Implantable meshes for controlling the movement of fluids (2016-05-17),

14. 9327010 - Compositions and methods for promoting hemostasis and other physiological activities (2016-05-03),

15. 9162005 - Compositions for prevention of adhesions and other barrier applications (2015-10-20),

Title: Innovations by Rutledge Ellis-Behnke

Introduction

Rutledge Ellis-Behnke is a prominent inventor based in Canton, MA (US). He has made significant contributions to the field of medical technology, holding a total of 18 patents. His work focuses on innovative solutions that enhance surgical procedures and improve patient outcomes.

Latest Patents

Among his latest patents is a self-assembling peptide gel formulation and methods of use. This invention involves compositions containing self-assembling peptides that can create a long-lasting “lift” for tissues during surgical procedures. The gel is stable for an extended period, is hemostatic, and helps prevent adhesions. This technology enables better tissue separation, visualization of margins, and reduces the need for frequent injections, thereby minimizing risks during minimally invasive surgeries. Another notable patent involves compositions and methods for promoting hemostasis and other physiological activities. These compositions include nanoscale structured materials and can be used to protect wounds, isolate tissue, and serve as bulking agents. They are also applicable in medical devices, bandages, and kits.

Career Highlights

Rutledge has worked with notable organizations such as Arch Biosurgery, Inc. and the Massachusetts Institute of Technology. His career reflects a commitment to advancing medical technology through innovative research and development.

Collaborations

He has collaborated with esteemed colleagues, including Terrence Norchi and Gerald E. Schneider, contributing to the advancement of medical innovations.

Conclusion

Rutledge Ellis-Behnke's work exemplifies the intersection of innovation and healthcare, showcasing how inventive solutions can lead to improved surgical techniques and patient care. His contributions continue to influence the medical field significantly.

Profile summary based on public USPTO records.